Introduction
Several murine models of lupus have contributed significantly to our understanding of the genetic and pathogenic basis of this disease. [1] [2] [3] [4] In particular, the BWF1 (F1 intercross between NZB and NZW) and NZM2410 (an inbred strain comprised genomically of 75% NZW and 25% NZB) lupus strains have been extensively analyzed with respect to the genomic locations of susceptibility loci for antinuclear antibodies (ANAs), glomerulonephritis (GN), and other component lupus phenotypes. [5] [6] [7] [8] [9] [10] [11] [12] [13] In addition, genetic studies in the BXSB and MRL/lpr strains have also shed light on additional loci predisposing to lupus. [14] [15] [16] [17] [18] [19] [20] Among the different loci identified in these studies, four certainly appear to tower above the rest, as they light up in most of the studies. These include loci on Chr 1 (Sle1/Nba2), 4 (Sle2/Lbw2/Sbw2, and Nba1), 7 (Sle3/Sle5), and 17 (H2). More recently, congenic dissection studies have also shed light on the respective roles of these loci in disease pathogenesis. [21] [22] [23] [24] [25] [26] [27] The (SWR × NZB)F1 (or SNF1) hybrid model is another strain which develops lupus nephritis that is clinically very similar (in onset, severity, female bias, and pathology) to the BWF1 disease. Studies in this model have clearly demonstrated the relative contributions of antigen-specific, and antigen non-specific modalities of T cell: B cell cross-talk in orchestrating disease, as reviewed. 28, 29 A recent genetic analysis has unraveled the dominant SWR contributions to disease in this model. 30 In that study, linkage analysis using a panel of NZB × SNF1 backcross (BC) mice revealed the existence of four dominant SWR loci: H2 (Chr 17, SWR dominant, linked to early mortality, GN and IgG ANAs), Swrl-1 (Chr 1, SWR dominant, linked to IgG ANAs), Swrl-2 (Chr 14, SWR dominant, linked to GN), and Swrl-3 (Chr 18, SWR dominant, linked to IgG ANAs). In addition, that study also pointed to the existence of two recessive NZB contributions, both on Chr 4: Lbw2/Sbw2, and Nba1, linked to early mortality and GN, respectively.
Since the SNF1 is a hybrid model of lupus, dominant loci from the parental strains must be contributing to disease. However, the direction of the previously reported BC precludes the identification of any such dominant NZB loci (or any recessive SWR contributions). In order to ascertain the potential contributions of such loci, a panel of 88 (SWR × SNF1) BC mice were analyzed in the present study, to ascertain if the development of autoantibodies (autoAbs), GN, or early mortality is linked to any specific (dominant) NZB or (recessive) SWR loci, using a panel of 116 microsatellite markers, spanning all 19 autosomes.
Results

Correlation between serology and disease
As detailed in the Materials and methods, for each of the analyzed phenotypes, BC mice were classified as being 'negative', 'low-positive', or 'high-positive' (as summarized in Table 1 ). As illustrated in Table 2 , only about 20- 40% of the BC progeny are positive (both low and high, combined) for the different component phenotypes of lupus, including autoAbs, GN, or early mortality. This is consistent with the notion that two or more loci, in various epistatic combinations, are required for the expression of the different phenotypes. It is also clear from Table 2 that IgG anti-dsDNA and anti-ssDNA ANAs in these mice correlate with GN and/or early mortality. None of the IgM antibodies assayed correlate with GN or early mortality. Interestingly, there is poor correlation between early mortality and GN, in this data set.
Mapping of loci for autoantibodies
The polygenic nature of lupus in this murine model is apparent from the data in Table 3 . Of the nine loci linked to Ab production (identified at a significance level of P Ͻ 0.01), five reach the 'suggestive' level of significance. Interestingly, all five of these loci map to regions that have been previously implicated in lupus susceptibility. They comprise of two SWR-derived recessive loci (Swrl-1 and Swrl-4), and three NZB-derived dominant loci (Nba4, Lbw4, and Nba5). No loci were linked to IgM anti-DNP-KLH and IgM anti-histone Abs. Swrl-1 was recently identified as a dominant SWRderived locus, with a peak on Chr 1 at 86 cM, linked to IgG autoantibody formation in the NZB × SNF1 BC. 30 It is interesting to note that in the present study, ANA formation is not linked to Swrl-1, which is consistent with the notion that this phenotype is truly dominant (and hence would not be identified in the present cross, where all offspring bear at least one SWR allele at Swrl-1). Instead, in this study, Swrl-1 is recessively linked to elevated serum IgG3. Thus, the recessive trait of elevated serum IgG3 may represent a phenomenon that is contingent upon the dose-dependent expression of Swrl-1, or a Depicted in the top three rows are the percentages of mice (n = 88) that were 'normal', 'low-positive', or 'high-positive', for the given phenotype, categorized as indicated in Table 1 . Chi-square tests were performed using a 3 × 3 contingency matrix, with 4 degrees of freedom. Indicated values represent statistical P-values. NS = not significant; GN = glomerulonephritis.
upon the epistatic interaction with other 'background' genes. Alternatively, this might represent a closely linked gene on Chr 1, that is distinct from the one that drives ANA formation.
All three NZB-derived 'suggestive' loci conferring susceptibility to ANA formation corroborate previously identified loci. The locus on centromeric Chr 5 (peak at 11 cM, termed Nba4) is linked to elevated total IgG3 and IgG anti-histone Abs. Interestingly, this locus maps similarly as Sle6, an NZW-derived locus mapped by Morel et al, 13 in (NZW × B6.Sle1) × NZW BC mice, linked to GN. Though it could be proposed that the elevated IgG3 which the Nba4 locus is linked to, might be causally related to GN, this locus does not appear to be directly linked to GN in the present study. A second NZB locus that has previously been linked to lupus is Lbw4 on Chr 6 (peak at 63 cM). 7 Morel et al 12 have also identified a similarly positioned B6-derived locus on Chr 6 (peak at 60 cM), also linked to IgG anti-dsDNA formation. In view of the chromosomal position and the linked phenotype, the Ab susceptibility locus on Chr 6 identified in the present study is likely to be Lbw4. A third dominant NZB contribution to autoantibody formation lies on distal Chr 7, peaking at 52 cM. Interestingly, Vyse et al 10 have previously identified an NZB locus for IgG autoantibody formation, at the identical position. This locus is assigned the name, Nba5.
Finally, an SWR-derived locus on Chr 10 (peak at 25 cM) is linked to IgG or IgM ANAs at the suggestive level (LOD = 2.11), and is also weakly associated with GN (LOD = 1.1). Drake et al 6 have previously reported an NZB-derived GN susceptibility locus at the identical position. Thus, it is conceivable that the SWR allele at this position might be more 'potent' than the NZB allele, in conferring disease susceptibility. This locus is assigned the name, Swrl-4.
In addition to the above five loci, four other loci are linked to Ab formation, with LOD Ͼ 1.43, but are subthreshold for classification as being 'suggestive' (Table 3) . Nevertheless, it should be pointed out that most of these loci also co-map with previously identified lupus susceptibility loci. The SWR locus on Chr 1 (33 cM, linked to IgG anti-dsDNA and IgG anti-ssDNA ANAs) maps similarly as the BXSB-derived Bxs1 locus.
14 The NZB-derived locus on centromeric Chr 3 (peak at 17 cM) maps close to the Sles3 locus identified by Morel et al. 13 Likewise, the distal locus on Chr 10 (peak at 66 cM) linked to elevated IgG3 maps similarly as an NZM-derived GN-susceptibility locus described by Morel et al. a Indicated in parentheses are the chromosomal positions (in cM) of the respective markers, from the acromere.
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b Where the mapped loci co-map with previously mapped NZB/NZM loci, the previously assigned names are indicated. Statistically suggestive SWR/NZB susceptibility loci that corroborate previously mapped loci in other independent crosses have been assigned names, as detailed in Materials and methods.
c The interval mapping function of MapManager was used to calculate LOD scores, as described in Materials and methods. Loci with linkages exceeding significance values of P Ͻ 0.01 at the peak, are listed, together with the corresponding LOD scores at 2 cM intervals around the peak. LOD scores in excess of 1.9 (P Ͻ 0.0034) are shown in bold. None of the LOD scores exceeded 3.3 (P Ͻ 1 × 10 −4 ). d Markerspecific LOD scores were calculated using the Pearson's 2 test (with 1 degree of freedom). LOD scores in excess of 1.9 (P Ͻ 0.0034) are shown in bold.
e ss = IgG anti-ssDNA ANAs; ds = IgG anti-dsDNA ANAs; h = IgG anti-histone ANAs; hd = IgG anti-histone/DNA ANAs; G3 = elevated serum IgG3; Mss = IgM anti-ssDNA. As detailed in Materials and methods the phenotypes were classified as being negative or positive using one of three classification modes: A (negatives vs all positives), B (high-positives vs all others), or C (extreme phenotype analysis). Listed are the phenotype-classification schemes that furnished any linkage at P Ͻ 0.01, at the indicated loci. The classification mode that yielded the highest LOD score is always listed first.
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e As detailed in Materials and methods the phenotypes were classified as being negative or positive using one of three classification modes: A (negatives vs all positives), B (high-positives vs all others), or C (extreme phenotype analysis). Listed are the phenotype-classification schemes that furnished any linkage at P Ͻ 0.01, at the indicated loci. The classification mode that yielded the highest LOD score is always listed first.
Mapping of loci for GN and early mortality
Among the two loci conferring susceptibility to GN (Table 4) , the contribution on Chr 7 (peak at 31 cM) reaches the suggestive level of significance. This locus maps similarly as the NZM/NZW derived Sle3 locus, 11 and the NZB-derived Nba3 locus, 6 both of which are also linked to GN. This locus is therefore likely to be Nba3. The SWR-derived recessive contribution to GN (Chr 5, peak at 58-60 cM) does not reach the suggestive level of significance, but maps close to the MRL-derived lupus susceptibility locus, Lprm4. 20 Of the two loci that confer susceptibility to early mortality, the NZB-derived contribution on centromeric Chr 10 (peak at 4 cM) reaches suggestive significance. However, this appears to be a novel region to which no previous lupus susceptibility loci have been mapped. A second (SWR) locus for early mortality maps to centromeric Chr 9. Though this locus fails to reach statistical significance, interestingly, it comaps with the NZW-derived GN-modulating locus, Sles4, identified by Morel et al.
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Discussion
Together with the recently completed NZB × SNF1 BC analysis, 30 the present study reveals the truly polygenic nature of lupus in the SNF1 model. The earlier study had identified four dominant SWR contributions, and two recessive NZB contributions. The observation that none of those loci (with the partial exception of Swrl-1) are identified in the present study supports the notion that the SWR-derived H2, Swrl-1 (on Chr 1), Swrl-2 (on Chr 14), and Swrl-3 (on Chr 18) loci are acting in a totally dominant fashion, whereas the two NZB loci (Nba1 and the NZB locus that maps similarly as Sle2, Lbw2, and Sbw2) are truly recessive. Likewise, most of the loci identified in the present study were not revealed in the previous BC analysis, again pointing to the 'SWR recessive' and 'NZB dominant' nature of these loci. Of the five dominant NZB loci reaching statistical significance in this study, four corroborate previously mapped loci: Nba4, Lbw4, Nba5, and Nba3. It is particularly intriguing to review the phenotypic manifestations of these different loci in the different mapping crosses.
The NZB dominant locus on centromeric Chr 5, assigned the name Nba4, has also been mapped in the NZB × SNF1 BC analysis, as an NZB-recessive locus for IgG ANA formation. 30 Taking these two BC analyses together, it appears likely that the Nba4 locus is really facilitating ANA formation in a dose-dependent manner. Sle6 is an NZW-derived locus that was mapped to the same region by Morel et al, 13 being strongly linked to GN (LOD = 3.63), and weakly to ANAs (LOD = 1.47). How-ever, this locus was not mapped in crosses where the NZM (which bears the NZB allele at this locus) and B6 alleles were segregating, 11 or where the NZB and NZW alleles were segregating. 5, 7 Thus, the phenotypic expression of this locus is likely to be dependent on the 'background' genomic context. Obviously, these predictions need to be verified with congenic dissection analyses.
Lbw4 is an NZB-derived mortality locus mapped to Chr 6 (peak at 63 cM) by Kono et al 7 using a (NZB × NZW)F2 intercross panel. Indeed, in a cross where NZM/B6 alleles were segregating, a similarly positioned B6-derived chromosomal interval was identified to confer susceptibility to ANA formation, including anti-dsDNA ANAs. 12 These two earlier reports suggest that the NZB and B6 alleles at this locus may potentiate disease, whereas the NZM or NZW alleles might be protective. Our findings support this notion, and suggest that the SWR allele at this locus is also likely to confer protection. Whether the primary phenotype(s) triggered by this locus is ANA formation and/or mortality needs to be ascertained by congenic dissection.
The dominant NZB contribution on Chr 7 (peak at 52 cM), named here as Nba5, was first reported by Vyse et al, 10 as an NZB-dominant locus for ANA generation (IgG anti-histone/DNA, IgG anti-ssDNA, and IgG antidsDNA ANAs). It is heartening to note that the Nba5 locus mapped in the present study matches the locus reported by Vyse et al, 10 in genomic position, strain of origin and mode of inheritance, and also the linked phenotype. Thus, whereas the NZW and SWR alleles at this locus are likely to be protective, the NZB allele clearly facilitates ANA formation.
The NZB dominant locus, Nba3, was mapped by Drake et al, 6 to Chr 7 (peak at 37 cM), as conferring GN susceptibility, using a (NZB × SM/J)F1 × NZW cross. In addition, two other mapping studies have mapped GN susceptibility to this vicinity. Morel et al, 11 mapped GN susceptibility to the p locus on Chr 7 (peak at 28 cM), where the NZM/NZW allele promotes disease, and the B6 allele is protective. Santiago et al, 15 have also mapped GN susceptibility to a NZW locus on Chr 7 (peak at 25 cM). The NZB dominant locus for GN on Chr 7 that is mapped by the present analysis is positioned between these loci, with a peak at 31 cM. In view of the genomic location, strain of origin and mode of inheritance, and the associated phenotype, this locus is indeed likely to be Nba3.
Finally, the present analysis also reveals a locus on centromeric Chr 10 that is associated with early mortality. Though this locus reaches the suggestive level of statistical significance, it does not corroborate any previously mapped loci. This locus is therefore not assigned a name. Further confirmation with independent crosses is clearly warranted for the recognition of this locus as a significant contributor to lupus pathogenesis.
Taking both the (NZB × SNF1), and the present (SWR × SNF1) BC studies into consideration, one can now appreciate the respective contributions of the two parental strains to disease, in the SNF1 lupus model. Since this is a hybrid model, recessive SWR and NZB genes are unlikely to be at play, unless both the NZB and SWR alleles are functionally identical, at any given locus. Figure 1 depicts all dominant SWR and NZB contributions that are currently known to impact the development of lupus, at least at the suggestive level of statistical
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Figure 1
Eight dominant loci contribute to lupus in the SNF1 model. All dominant SWR and NZB loci that reach the suggestive level of significance are portrayed, with respect to the phenotypes they impact. Since the SNF1 is a hybrid model, recessive loci such as Swrl-4 and Nba1 are not likely to be at play in these mice, and have hence been excluded. The dominant SWR contributions have been previously detailed, 30 whereas the dominant NZB loci are described in this manuscript.
significance. It appears likely that both strains are contributing three potent loci, each, towards ANA formation. Currently, the extent to which the contributions of these loci are redundant (or complementary) is unclear. GN in the SNF1 model is very likely to be the result of at least three dominant contributions: H2 (SWR-derived, on Chr 17), Swrl-2 (SWR-derived, on Chr 14), and Nba3 (NZBderived, on Chr 7). Finally, there appears to be two dominant contributions to early mortality: H2 (SWR-derived, on Chr 17), and an NZB-derived locus on centromeric Chr 10 (not shown). Note that Swrl-4 (that contributes to ANA formation, Table 3 ) and Nba1 (that confers GN susceptibility) 30 are both excluded from this Figure as they both function in a recessive manner. In addition, the Nba2 locus on Chr 1 6 does not appear to be a pathogenic player, as the SWR allele at the same locus (ie, Swrl-1) is a more potent susceptibility factor. 30 Though the NZB strain is classically acknowledged as being autoimmune, and the SWR strain is recognized to be phenotypically normal, it is now clear that both strains are contributing fairly equally to disease in the hybrid model. Among the eight dominant loci portrayed in Figure 1 , the locus that clearly towers above the rest, in terms of LOD scores and the spectrum of phenotypes linked to, is the SWRderived H2 locus. Though the critical importance of this locus to lupus pathogenesis has long been recognized in almost all murine models, the molecular basis of this locus remains a mystery, as discussed previously. 30 The above findings resonate well with the genetic studies performed in the NZM, BWF1, MRL, and BXSB lupus models, as reviewed. [1] [2] [3] [4] It is clear that lupus is the endproduct of several genetic aberrations, each nudging the immune system a little closer towards autoreactivity. Effective B-cell tolerance and T-cell tolerance necessitates the proper operation of an elaborate series of central and peripheral checkpoints. It is conceivable that the different ANA susceptibility genes are indeed infringing these tolerance checkpoints differentially. The collective input of several such loci might be necessary to breach immune tolerance, and surpass the threshold for frank ANA formation. How, the inherited genetic load can dictate the stepwise evolution of ANA specificities and end-organ disease in lupus, has recently been demonstrated. 23, 25, 26 Though these studies point to the genomic locations of key lupus susceptibility loci in the SNF1 model, virtually nothing is known about the culprit genes within these loci, or their potential functions. Derivation and analyses of congenic strains on a 'normal' genetic background, and decoding the actual genes within the implicated loci, are the challenges that lie ahead.
Materials and methods
Mice and phenotyping
The derivation of the 88 (SWR × SNF1) BC mice in 1979/1980 has previously been detailed. 31, 32 Thus, all loci in the progeny from this cross bear at least 1 SWR allele (derived from the SWR parent), while the other allele is either SWR or NZB in origin, as it arises from the F1 parent. Mice were sero-tested at 9-12 months of age, or earlier if moribund. Seropositive mice were monitored for evidence of proteinuria, at weekly intervals, using albustix strips. Mice that exhibited persistent proteinuria for two consecutive weeks, or appeared moribund, were sacrificed. Upon sacrifice, their kidneys were examined for evidence of GN. The glomeruli were screened for evidence of hypertrophy, proliferative changes, hyaline deposits, and/or basement membrane thickening, in a blinded fashion. The severity of GN was graded on 0 to 4 scale, in which the grades 1, 2, 3, and 4, were accorded when 1-10%, 11-25%, 26-50%, and Ͼ50% of the glomeruli were affected, respectively, as detailed elsewhere. 33 The following phenotypes were used for linkage analysis: serum IgG ANAs, IgM Abs, total serum IgG3, histological GN, and age of death. Since IgG3 has been associated with cryoglobulinemia and consequent renal disease, 34, 35 this phenotype was also analyzed in the present study. The ANA specificities that were examined are detailed below. No significant sex bias was seen in any of the phenotypes studied. Therefore, the data from both the male and female progeny were combined for analysis. For all phenotypes studied, the mice were arbitrarily classified as being negative, low-positive, or strong-positive, following the criteria listed in Table 1 . As detailed below, these phenotypic categories were classified in three different ways, for the purpose of linkage analysis.
ELISA for total Ig
Total serum IgM and IgG levels were assayed using a sandwich ELISA. Briefly, goat anti-mouse IgM or IgG (Boehringer Mannheim, Indianapolis, IN, USA) was first coated onto Immulon I plates, and blocked. Sera was diluted serially and added to the plates for 2 h at room temperature. Bound Ig was revealed with alkalinephosphatase conjugated goat anti-mouse IgM or IgG Abs (Boehringer Mannheim), using p-nitrophenyl phosphate as a substrate. Serial dilutions of isotype-specific Ig standards were also added to each plate, for quantitation and inter-plate standardization.
ELISA for autoantibodies
In this communication, 'ANA' refers to a specific set of antinuclear antibodies (ie, anti-dsDNA, anti-ssDNA, antihistone/DNA and anti-histone antibodies) as assayed by ELISA, not immunofluorescence. The IgG anti-dsDNA, anti-ssDNA, anti-histone and anti-histone/DNA ELISAs were carried out as detailed elsewhere. 36 Briefly, for the anti-dsDNA ELISA, Immulon II plates (Dynatech, Chantilly, VA, USA) precoated with methylated bovine serum albumin (mBSA), were coated overnight with 50 g/ml dsDNA (Sigma Chemicals, dissolved in PBS, and filtered through cellulose acetate before use). For the antihistone/DNA ELISA, the dsDNA-coated plates were then post-coated with 10 g/ml of 'total' histones (a mixture of all histones, purchased from Boehringer Mannheim), overnight at 4°C. It should be noted that the anti-histone/DNA ELISA picks up a broad range of ANAs, including anti-dsDNA, anti-histone, and bonafide anti-nucleosome Abs. After blocking with PBS/3% BSA/0.1%gelatin/3 mM EDTA, 1:100 dilutions of the test-sera, were incubated in duplicate for 2 h at room temperature. Bound IgG was detected with alkaline phosphatase-conjugated anti-mouse IgG (Jackson Immunoresearch, West Grove, PA, USA), using p-nitrophenyl phosphate as a substrate. Raw OD was converted to Units/ml (U/ml), using a positive control serum derived from an NZM2410 mouse, arbitrarily setting the reactivity of a 1:100 dilution of this serum to 100 U/ml. IgM anti-ssDNA, IgM anti-histone, and IgM anti-DNP-KLH Abs were assayed as described elsewhere. 22 With all ELISA assays, sera with reactivities stronger than the test standard were diluted further and re-assayed. The Ab serotiters in the BC mice were compared to sera from a panel of 12, 9 to 12 month-old SWR control mice. NZB sera were not used as controls as they exhibit autoAbs, notably anti-ssDNA ANAs, by this age. Serotiters that exceeded the SWR means by 3, or 8, standard deviations, were arbitrarily classified as being low-positive, or strong-positive, respectively, as indicated in Table 1 .
Genotyping
Oligonucleotide primers flanking microsatellite repeats were synthesized commercially (IDT, Coralville, IA, USA). A panel of 116 primers that readily distinguished SWR from NZB alleles, were utilized. Together, they spanned 1500 cM of the autosomal genome (covering all 19 chromosomes), with an average inter-marker distance of 10.6 cM. The sequences of the selected primers are publicly available (http://www-genome.wi.mit.edu/). The chromosomal positions of the primers with respect to the acromere are reported in accordance with the Mouse Chromosome Committee Reports obtained through the Encyclopedia of the Mouse Genome, Mouse Genome Database, The Jackson Laboratory, Bar Harbor, ME, USA (http://www.imformatics.jax.orgl). Genotyping was performed using tail DNA. PCR amplification was performed in an Eppendorf MasterCycler (Eppendorf Scientific), generally using 30 cycles of: 30 s at 94°C, 1 min at 55°C, 30 s at 72°C. For certain primers the annealing temperature was ramped up to 60°C or ramped down to 50°C, for optimal results. Amplified products were electrophoresed onto 5% agarose gels, and visualized by ethidium bromide staining and UV transillumination. The mice were then scored as being 'S' (or 'SS', homozygous for the SWR allele), or 'H' (heterozygous for SWR/NZB alleles).
Linkage analysis and statistics
For each of the phenotypes analyzed, the existence of statistically significant linkage to any chromosomal regions was determined using two different algorithms, as described. 37 Interval mapping was first performed using MapManager.QTX (http://mapmgr.roswellpark. org/mapmgr.html) The latter is a QTL mapping program that tests if any chromosomal intervals show evidence of linkage to the tested phenotypes, using the Kosambi mapping function. Next, for each of the intervals identified by interval-mapping, marker-specific linkage analysis was performed for the anchor marker closest to the peak of the susceptibility interval, using the Pearson's 2 test. The LOD scores derived by both algorithms are presented in the Results. As is evident from the results, there is very good concordance between these two algorithms.
All phenotype data were classified and analyzed in three different modes. In mode A, all offspring were classified as being either 'negative', or 'positive' (which includes both the low-positives, and the high-positives), following the criteria outlined in Table 1 . In classification mode B, only the high-positives were considered to be 'positive', whereas all other progeny were classified as 'negative'. Finally, classification mode C entailed extreme phenotype analysis (negatives, and high-positives only), essentially excluding the low-positives from analysis. Thus, whereas classification modes A and B utilized all 88 progeny, mode C used only about 70-90% of the progeny, having excluded the low-positives.
Since genome-wide search essentially entails multiple hypotheses testing, a threshold for 'suggestive' linkage was set at log-likelihood of the odds (LOD) Ͼ1.9, P Ͻ 0.0034 ( 2 Ͼ 8.6, 1 df), based on the recommendation of Lander and Kruglyak. 38 The threshold for 'significant' or 'probable' linkage was set at a LOD Ͼ3.3, P Ͻ 1 × 10 −4 ( 2 Ͼ 15.1, 1 dof). In this communication, all loci showing evidence of linkage to any of the tested lupus traits at P Ͻ 0.01 are reported. Newly identified SWR/NZB loci that exhibit at least suggestive linkage (LOD Ͼ 1.9, by the interval mapping algorithm) were assigned names, if they corroborated previously mapped lupus susceptibility loci, from other independent crosses. SWR-derived loci were named Swrl-4 (SWR lupus locus 4), Swrl-5, etc. Swrl-1, Swrl-2 and Swrl-3 have been recently documented. 30 NZB-derived loci were named Nba4 (New Zealand Black autoimmunity locus 4), etc, in compliance with previous nomenclature. 5 Correlation between serum ANA, GN, and mortality was performed using the 2 test, after classifying individual mice as being 'high-positive', 'low-positive', or 'normal', for each given phenotype. Likewise, epistatic interactions between loci were tested for using 2 test, with Yate's correction for continuity where necessary. However, due to the plurality of loci and the small numbers of mice in each composite category, we could not demonstrate any statistically significant epistasis, between the identified susceptibility loci.
